Empowered Patient Podcast

Dr. R.J. Tesi, President and CEO, INmune Bio shines light on the complexity of the immune system by pointing out that while much work has been done on the adaptive immune system, the key to treating Alzheimer's might be to address the dysregulated innate immune system due to chronic inflammation. R.J. talks about developing XPro1595 a second generation selective TNF inhibitor which is designed to reduce inflammatory activity in the brain. They are also validating novel neuroimaging techniques and biomarkers to help predict which patients may respond to treating neuroinflammation as an underlying cause of their Alzheimer's.

@INmuneBio #neuroinflammation #Alzheimers #cytokine #biotech #clinicaltrial #biomarkers #InnateImmuneSystem

INmuneBio.com

Listen to the podcast here

Dr. R.J. Tesi, President and CEO, INmune Bio shines light on the complexity of the immune system by pointing out that while much work has been done on the adaptive immune system, the key to treating Alzheimer's might be to address the dysregulated innate immune system due to chronic inflammation. R.J. talks about developing XPro1595 a second generation selective TNF inhibitor which is designed to reduce inflammatory activity in the brain. They are also validating novel neuroimaging techniques and biomarkers to help predict which patients may respond to treating neuroinflammation as an underlying cause of their Alzheimer's.

@INmuneBio #neuroinflammation #Alzheimers #cytokine #biotech #clinicaltrial #biomarkers #InnateImmuneSystem

INmuneBio.com

Download the transcript here

Mary Guillermin, Director of Communications and Senior Pellin Practicioner at the Pellin Institute International and author talks about her book John Guillermin: The Man, The Myth, The Movies a story about her husband the British writer and film director of such films as King Kong, The Towering Inferno, The Blue Max and Rapture. Mary talks about her own experience dealing with depression, the need to understand the mood swings of those with bipolar disease particularly of those creatives types like John, and why we need to destigmatize mental health care.

#WildMan #MentalHealth #MentalHealthAwareness #BiPolarAwareness #Worldbipolarday #OldHollywood #Knownforhistemper #JohnGuillermin

John Guillermin: The Man, The Myth, The Movies by Mary Guillermin

PellinInstitute.com

Listen to the podcast here

Mary Guillermin, Director of Communications and Senior Pellin Practicioner at the Pellin Institute International and author talks about her book John Guillermin: The Man, The Myth, The Movies a story about her husband the British writer and film director of such films as King Kong, The Towering Inferno, The Blue Max and Rapture. Mary talks about her own experience dealing with depression, the need to understand the mood swings of those with bipolar disease particularly of those creatives types like John, and why we need to destigmatize mental health care.

#WildMan #MentalHealth #MentalHealthAwareness #BiPolarAwareness #Worldbipolarday #OldHollywood #Knownforhistemper #JohnGuillermin

John Guillermin: The Man, The Myth, The Movies by Mary Guillermin

PellinInstitute.com

Download the transcript here

Stephanie Culler PhD, Co-Founder and CEO, Persephone Biosciences describes how the microbiome, the microbes that exist in our GI tract, impacts our overall health and specifically the immune system. Their goal is to leverage the impact of a healthy microbiome to improve the effectiveness of drugs and vaccines. By creating the VOICES study, Persephone is looking at a representative population to look at the connection between the microbiome and clearance of viral infections as well as vaccine efficacy to better understand how the microbiome is impacting a patient's response to the COVID-19 vaccines.

@persephonebio #GutMicrobiome #Microbiome #COVID19 #vaccine

PersephoneBiosciences.com

Listen to the podcast here

Stephanie Culler PhD, Co-Founder and CEO, Persephone Biosciences describes how the microbiome, the microbes that exist in our GI tract, impacts our overall health and specifically the immune system. Their goal is to leverage the impact of a healthy microbiome to improve the effectiveness of drugs and vaccines. By creating the VOICES study, Persephone is looking at a representative population to look at the connection between the microbiome and clearance of viral infections as well as vaccine efficacy to better understand how the microbiome is impacting a patient's response to the COVID-19 vaccines.

@persephonebio #GutMicrobiome #Microbiome #COVID19 #vaccine

PersephoneBiosciences.com

Download the transcript here

Maria Maccecchini PhD, Founder, President, CEO, Annovis Bio has been on the path to find a way to protect nerve cells to maintain overall health. Lead therapy ANVS401 (phase 2) is designed to treat Alzheimer's, Parkinson's and other neurodegenerative diseases by tapping into the brain's defense mechanism to get rid of toxic proteins that impair axonal transport, the body's information highway. Affecting the manufacture of amyloid, tau and alpha-synuclein, the treatment is lowering inflammation and showing statistical improvement in function.

#Alzheimers #Parkinsons #axonaltransport

Annovisbio.com

Listen to the podcast here

Maria Maccecchini PhD, Founder, President, CEO, Annovis Bio has been on the path to find a way to protect nerve cells to maintain overall health. Lead therapy ANVS401 (phase 2) is designed to treat Alzheimer's, Parkinson's and other neurodegenerative diseases by tapping into the brain's defense mechanism to get rid of toxic proteins that impair axonal transport, the body's information highway. Affecting the manufacture of amyloid, tau and alpha-synuclein, the treatment is lowering inflammation and showing statistical improvement in function.

#Alzheimers #Parkinsons #axonaltransport

Annovisbio.com

Download the transcript here

Usama Malik, CEO, Fore Biotherapeutics is aiming to treat patients with rare cancer mutations with a hyper targeted precision or personalized approach by using the Fore AI-based technology platform to investigate which drugs might work best for each mutation. While most cancer companies focus only on the most prevalent mutations, Fore is expanding the search by looking at hundreds of mutations to identify driver mutations that actively contribute to the growth of tumors. Fore is in search of unaddressed patient populations and patients where existing therapeutics are not working.

#ForeBiotherapeutics #cancer #raredisease #oncology #BRAF #precisionmedicine #personalizedmedicine #DriverMutations

Fore.Bio

Listen to the podcast here

Usama Malik, CEO, Fore Biotherapeutics is aiming to treat patients with rare cancer mutations with a hyper targeted precision or personalized approach by using the Fore AI-based technology platform to investigate which drugs might work best for each mutation. While most cancer companies focus only on the most prevalent mutations, Fore is expanding the search by looking at hundreds of mutations to identify driver mutations that actively contribute to the growth of tumors. Fore is in search of unaddressed patient populations and patients where existing therapeutics are not working.

#ForeBiotherapeutics #cancer #raredisease #oncology #BRAF #precisionmedicine #personalizedmedicine #DriverMutations

Fore.Bio

Download the transcript here